Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Research is Scopus-indexed (Q1, CiteScore 17), WoS SCIE. Published by American Association for Cancer Research Inc..
Checked against the index lists dated .
ISSN 0008-5472Verify ISSN ↗1538-7445Verify ISSN ↗
Publisher: American Association for Cancer Research Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 25 / 428 | 94th | Q1 |
| Cancer Research | 19 / 233 | 92nd | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1941–present, best quartile Q1, CiteScore 17.
Cancer Research is Q1 in Oncology (rank 25 of 428) and Q1 in Cancer Research (rank 19 of 233), by CiteScore 2025.
Cancer Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 17, which places it in quartile Q1 at the 94th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 4.347, quartile Q1, with an H-index of 522.
Cancer Research is published by American Association for Cancer Research Inc. Its print ISSN is 0008-5472 and its online ISSN is 1538-7445.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cancer Research has an h-index of 471 and a 2-year mean of 0.58 citations per paper (OpenAlex). Its Scopus CiteScore is 17, quartile Q1. On 2-year citations it ranks #325 of 424 Scopus journals in Oncology.
Cancer Research published 8,266 papers in 2025; its busiest recent year was 2024 with 11,114. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2026), authors are most often from United States (43.9%), China (27.9%) and Canada (4.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 170 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.